What we treat
Home/Guides & Tips/Medication/

Rybelsus for weight loss: does it work and is it right for you?

Rybelsus is a once-daily tablet containing semaglutide. It's licensed for type 2 diabetes, but is sometimes used off-label for weight loss.

iconUpdated 6th July 2026
Research-Based Guide

Rybelsus is the oral form of semaglutide, the same active ingredient as Wegovy and Ozempic injections. It's licensed for type 2 diabetes in the UK, but some private prescribers may prescribe it off-label for weight loss.

The Wegovy pill also contains semaglutide in tablet form, but at a higher dose and licensed specifically for weight loss. The Wegovy pill is now approved in the UK by the MHRA and available through Voy.

Here's how Rybelsus works, who it suits, and how it compares to other GLP-1 weight loss treatments.

Key Takeaways:

  • Rybelsus is a once-daily tablet containing semaglutide, the same active ingredient as Wegovy and Ozempic
  • It's licensed in the UK for type 2 diabetes, and sometimes prescribed off-label for weight loss
  • In a UK study, adults with type 2 diabetes taking Rybelsus lost around 4.8kg (4.6% of body weight) over 38 weeks
  • The formulation changed in September 2025: new lower doses (1.5mg, 4mg, 9mg) replaced the original strengths (3mg, 7mg, 14mg) with the same effect
  • Rybelsus is less effective for weight loss than medications specifically licensed for it like Wegovy injections, Wegovy pill or Mounjaro

What is Rybelsus?

Rybelsus is a prescription tablet containing semaglutide, a GLP-1 receptor agonist. It's licensed by the MHRA to help adults with type 2 diabetes control their blood sugar.

It contains the same active ingredient as Wegovy and Ozempic injections, but is taken as a daily tablet rather than a weekly injection. Wegovy and Ozempic both use semaglutide, but Wegovy is licensed for weight loss while Ozempic is licensed for type 2 diabetes.

How does Rybelsus work?

Rybelsus mimics a natural gut hormone called GLP-1. This hormone is released after eating and helps regulate blood sugar and appetite.

By acting like GLP-1, Rybelsus:

  • Slows down how quickly food leaves the stomach, helping you feel fuller for longer
  • Suppresses appetite and reduces cravings, including preferences for high-fat foods
  • Stimulates insulin release when blood sugar rises after a meal
  • Tells the liver to make less glucose

Most people start to notice changes within a few weeks, with the full effect building gradually over months as the dose increases.

Is Rybelsus used for weight loss?

No, Rybelsus is only licensed for type 2 diabetes. Some private prescribers may offer it off-label for weight loss, but it isn't typically the first choice.

Other medications like Wegovy and Mounjaro are licensed specifically for weight loss and produce greater results. If you're looking for weight loss treatment, these are usually recommended first.

Check your BMI today
Not sure where you stand? Calculate your BMI and find out what it means for you.

Does Rybelsus work for weight loss?

Yes, but the weight loss is modest compared to other GLP-1 medications.

In a UK study, adults with type 2 diabetes taking Rybelsus lost an average of 4.8kg (4.6% of their body weight) over 38 weeks.

For comparison:

Rybelsus may be a good option if you have type 2 diabetes and could benefit from some weight loss too. But Rybelsus contains a much lower dose of semaglutide than the Wegovy pill or Wegovy injection, and it's licensed for blood sugar control, not weight loss. That's why the results are smaller than with medications designed specifically for weight loss.

Has Rybelsus changed?

Yes. In September 2025, Novo Nordisk launched a new formulation of Rybelsus with lower-numbered doses. The tablets are also smaller and round, where the older ones were oval.

Here's how the doses match up:

  • 3mg is now 1.5mg (starting dose)
  • 7mg is now 4mg (maintenance dose)
  • 14mg is now 9mg (maintenance dose)

The lower-numbered tablets contain less semaglutide, but your body absorbs them better. So although a 9mg tablet sounds weaker than the old 14mg, it's just as effective.

Novo Nordisk began phasing out the old formulation in late January 2026, though some stock may still be around.

How many Rybelsus tablets should you take per day?

Take one tablet per day, no matter which version you've been given. Don't double up to match the old dose. Taking more than one tablet a day can lead to an overdose and more side effects.

If you're not sure which version you have, ask your prescriber or pharmacist.

What's the Rybelsus dose schedule?

Rybelsus is taken as one tablet per day. The dose starts low and increases over time so your body has time to adjust.

Here's how the dose increases:

  • Start at 1.5mg (or 3mg in the old formulation) for at least 30 days
  • Move up to 4mg (or 7mg) for at least another 30 days if you're tolerating it
  • Increase to the maximum 9mg (or 14mg) for ongoing maintenance if tolerated

How do you take Rybelsus?

  • Take on an empty stomach after at least 8 hours of fasting, ideally first thing in the morning
  • Swallow whole with a small sip of water (up to 120ml)
  • Don't break, crush, or chew the tablet, since this affects how well it's absorbed
  • Wait at least 30 minutes before eating, drinking, or taking other oral medication

Rybelsus vs Wegovy pill

Rybelsus and the Wegovy pill both contain semaglutide, but they're not the same medication.

Rybelsus
Wegovy pill
Active ingredient
Semaglutide
Semaglutide
Manufacturer
Novo Nordisk
Novo Nordisk
Maximum dose
9mg (new) / 14mg (old)
25mg
Licensed for
Type 2 diabetes
Weight loss
Weight loss results
4.6% over 38 weeks
16.6% over 64 weeks
UK availability
Available
Available

In trials, the Wegovy pill produces around three times more weight loss than Rybelsus. That's because it uses a much higher dose of semaglutide and is licensed for weight loss, not blood sugar control.

Wegovy Pill is live
Explore everything that's new in weight loss - from Wegovy Pill and our treatment options to the latest offers, savings and expert guidance.

By entering I agree to the Terms and Conditions.

Rybelsus vs Foundayo (orforglipron)

Rybelsus and Foundayo are both once-daily oral GLP-1 tablets, but they use different active ingredients and are used for different things.

Rybelsus
Foundayo
Active ingredient
Semaglutide
Orforglipron
Manufacturer
Novo Nordisk
Eli Lilly
Maximum dose
9mg (new) / 14mg (old)
17.2mg
Licensed for
Type 2 diabetes
Weight loss
Weight loss results
4.8kg (4.6%) over 38 weeks
Around 11.1% over 72 weeks
Food restrictions
Empty stomach, wait 30 mins
None. Take any time, with or without food
UK availability
Available
Not yet (approved in US April 2026)

In trials, Foundayo produces around twice the weight loss of Rybelsus, and it's easier to take with no food or water restrictions. See our orforglipron vs tirzepatide guide for more on how Foundayo compares to Mounjaro.

How does Rybelsus compare to weight loss injections?

Rybelsus is taken as a daily tablet, while Wegovy and Mounjaro are weekly injections. There are some real differences in how they work in your body too.

Injections deliver the medication directly into your bloodstream, so more of the drug reaches your body and produces a stronger effect. Tablets like Rybelsus have to pass through the stomach, where only about 1% of the dose gets absorbed. That's why Rybelsus needs to be taken on an empty stomach with a strict 30-minute wait, while injections can be taken any time.

The other differences:

  • Frequency: Rybelsus is daily; Wegovy and Mounjaro are weekly
  • Convenience: Tablets suit people who'd rather avoid needles; injections are more straightforward for people who'd rather not think about timing every day
  • Effectiveness: Wegovy and Mounjaro produce four to five times more weight loss than Rybelsus (covered above)

If you're looking for weight loss treatment, Wegovy or Mounjaro are usually the better choice. Rybelsus isn't usually recommended because it's licensed for type 2 diabetes, not weight loss.

If you'd genuinely struggle with injections, the Wegovy pill is now approved in the UK and available through Voy. It contains the same active ingredient as Wegovy injections but in tablet form, taken once every morning on an empty stomach instead of a weekly jab. Orlos (orlistat) is also available as a weight-loss-licensed tablet, though it works differently by blocking fat absorption in the gut rather than suppressing appetite.

Curious about weight loss medications?
They can be a gamechanger when exercise and diet aren’t giving you the results you’d hoped for. Voy’s weight loss treatment combines science-backed medicines with a team of health experts cheering you on. Find out if it’s right for you today.
Science-backed treatment
Clinical support
Trusted by 100,000 UK customers

What are the side effects of Rybelsus?

Most Rybelsus side effects are mild to moderate digestive issues that ease as your body adjusts.

According to the Rybelsus safety information, the most common are:

  • Nausea (around 15% of people)
  • Diarrhoea (around 10%)
  • Vomiting (around 7%)
  • Stomach pain, bloating, indigestion, or constipation
  • Decreased appetite
  • Dizziness or tiredness

These usually appear in the first few months and tend to ease as you get used to the medication and dose.

When should you see a doctor?

Speak to your prescriber if you notice any side effects that worry you. In particular:

  • Severe stomach pain that may spread to your back, which could be a sign of pancreatitis
  • Swelling of your face, lips, or tongue, or trouble breathing, which could be a sign of a serious allergic reaction
  • Low blood sugar. This is more likely if you're taking Rybelsus alongside insulin or a sulphonylurea (like gliclazide) for diabetes
  • Vision changes. This is mainly a concern for people with diabetes who already have eye problems like diabetic retinopathy
  • Side effects that don't go away. Most side effects should ease within a few months. If they don't, your prescriber may suggest a lower dose

If any symptom feels severe or alarming, call 111 or 999 straight away.

Who shouldn't take Rybelsus?

Rybelsus isn't suitable for everyone. You shouldn't take it if:

  • You have type 1 diabetes
  • You're pregnant, breastfeeding, or trying to conceive
  • You've previously had a serious allergic reaction to semaglutide or any other ingredient in Rybelsus

Speak to your prescriber before starting Rybelsus if you have:

  • A personal or family history of medullary thyroid cancer (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
  • A history of pancreatitis
  • Kidney problems
  • Severe stomach conditions like gastroparesis (slow stomach emptying)
  • Diabetic eye problems like diabetic retinopathy

You should also let your prescriber know if you're taking insulin or a sulphonylurea (like gliclazide), as your dose may need adjusting to avoid low blood sugar. Also let your prescriber know about any other medications you're taking as Rybelsus can affect how some medications work.

Where can I get Rybelsus in the UK?

Because Rybelsus is licensed for type 2 diabetes, you can only get it on the NHS if you meet certain criteria for diabetes treatment. The NHS doesn't prescribe Rybelsus for weight loss.

Some private prescribers may offer Rybelsus off-label for weight loss. But because Wegovy and Mounjaro are licensed for weight loss and produce greater results, most prescribers will recommend those instead.

At Voy, we don't currently prescribe Rybelsus. If you're looking for weight loss treatment, you can take our short quiz to see if you're eligible for the Wegovy pill, Wegovy injections, Mounjaro, or Orlos (orlistat) instead.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.


FAQ

Rybelsus for Weight Loss: FAQ

Dr Earim Chaudry, MBBS

DisclaimerAt Voy, we ensure that everything you read in our blog is medically reviewed and approved. However, the information provided is not meant to replace professional medical advice, diagnosis, or treatment. It should not be relied upon for specific medical advice.
References
icon¹

Eli Lilly and Company. "FDA Approves Lilly's Foundayo™ (Orforglipron), the Only GLP-1 Pill for Weight Loss That Can Be Taken Any Time of Day Without Food or Water Restrictions." Eli Lilly and Company Investor Relations, 1 Apr. 2026, investor.lilly.com/news-releases/news-release-details/fda-approves-lillys-foundayotm-orforglipron-only-glp-1-pill.

icon²

Jastreboff, Ania M., et al. "Tirzepatide Once Weekly for the Treatment of Obesity." The New England Journal of Medicine, vol. 387, no. 3, 21 July 2022, pp. 205-216, doi.org/10.1056/NEJMoa2206038.

icon³

Medicines and Healthcare products Regulatory Agency. "Rybelsus® (Semaglutide Tablets): Transition to New Formulation and Risk of Medication Error." MHRA Drug Safety Update, vol. 19, no. 5, 17 Dec. 2025, www.gov.uk/drug-safety-update/rybelsus-r-semaglutide-tablets-transition-to-new-formulation-and-risk-of-medication-error.